LENVIMA caps 4 mg 30 pce
7680655120013
CH-65512
L01EX08
07.16.1.
Reimbursement limitations:
LENVIMA.01
Carcinome thyroïdien différencié (DTC)
Carcinome thyroïdien différencié, localement avancé ou métastatique, réfractaire à l'iode radioactif …
1 / 2
google
Details
- Product number
- 6551201
- CPT
- -
- Packaging group
- 30
- Unit
- Kapsel(n)
- Composition
- lenvatinibum 4 mg ut lenvatinibi mesilas, calcii carbonas, mannitolum, cellulosum microcristallinum, hydroxypropylcellulosum, hydroxypropylcellulosum substitutum humile, talcum, Kapselhülle: hypromellosum, E 171, E 172 (flavum), E 172 (rubrum), Drucktinte: lacca, E 172 (nigrum), kalii hydroxidum, propylenglycolum, pro capsula.
Articles (1)
Lenvima 4 mg, Hartkapseln
Kapseln
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
4.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
Reimbursement information
Public price
CHF 1583.35
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/10/2015
Authorization holder
Eisai Pharma AG
8050 Zürich
Authorization information
- Swissmedic authorization number
- 65512
- Drug name
- Lenvima, Hartkapseln
- Galenic form
- KAHA
- ATC Code
- L01EX08
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 19/08/2015
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- LENVIMA caps 4 mg 30 pce
- Description (DE)
- LENVIMA Kaps 4 mg 30 Stk
- Market launch
- 19/08/2015
- Narcotic (BTM)
- No